EVE Health Valuation
| EVE Stock | 0 0.00 0.00% |
EVE Health seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of EVE Health Group from examining the firm fundamentals such as current valuation of 5.24 M, and Profit Margin of (0.89) % as well as evaluating its technical indicators and probability of bankruptcy.
Price Book 4.3092 | Enterprise Value 5.2 M | Enterprise Value Ebitda (1.05) | Price Sales 2.4719 | Enterprise Value Revenue 2.4572 |
Overvalued
Today
Please note that EVE Health's price fluctuation is very steady at this time. Calculation of the real value of EVE Health Group is based on 3 months time horizon. Increasing EVE Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
EVE Health's intrinsic value may or may not be the same as its current market price of 0, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 8.4E-4 | Hype 0.001 | Naive 0.001 |
The intrinsic value of EVE Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EVE Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EVE Health Group helps investors to forecast how EVE stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EVE Health more accurately as focusing exclusively on EVE Health's fundamentals will not take into account other important factors: EVE Health Cash |
|
EVE Health Total Value Analysis
EVE Health Group is currently forecasted to have takeover price of 5.24 M with market capitalization of 5.27 M, debt of 74.85 K, and cash on hands of 1.1 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the EVE Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.24 M | 5.27 M | 74.85 K | 1.1 M |
EVE Health Investor Information
About 51.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. EVE Health Group had 6:5 split on the 1st of June 2022. Based on the key indicators obtained from EVE Health's historical financial statements, EVE Health Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.EVE Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. EVE Health has an asset utilization ratio of 84.57 percent. This implies that the Company is making USD0.85 for each dollar of assets. An increasing asset utilization means that EVE Health Group is more efficient with each dollar of assets it utilizes for everyday operations.EVE Health Ownership Allocation
EVE Health holds a total of 5.27 Billion outstanding shares. EVE Health Group retains substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.EVE Health Profitability Analysis
The company reported the revenue of 2.13 M. Net Loss for the year was (1.55 M) with profit before overhead, payroll, taxes, and interest of 827.83 K.About EVE Health Valuation
The stock valuation mechanism determines EVE Health's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of EVE Health Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of EVE Health. We calculate exposure to EVE Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EVE Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 877 K | 920.8 K |
Additional Tools for EVE Stock Analysis
When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.